|
NDUFB10 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.114200E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.644200E-01 |
| Normal-vs-Stage2 |
1.404840E-04 |
| Normal-vs-Stage3 |
2.312000E-01 |
| Normal-vs-Stage4 |
3.963600E-01 |
| Stage1-vs-Stage2 |
5.446300E-04 |
| Stage1-vs-Stage3 |
7.407400E-01 |
| Stage1-vs-Stage4 |
9.296800E-01 |
| Stage2-vs-Stage3 |
8.362100E-04 |
| Stage2-vs-Stage4 |
1.058770E-03 |
| Stage3-vs-Stage4 |
7.321800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.767350E-01 |
| Normal-vs-AfricanAmerican |
4.802400E-01 |
| Normal-vs-Asian |
2.009200E-01 |
| Caucasian-vs-AfricanAmerican |
9.130400E-01 |
| Caucasian-vs-Asian |
7.333200E-01 |
| AfricanAmerican-vs-Asian |
7.306400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.909900E-02 |
| Normal-vs-Female |
9.643900E-02 |
| Male-vs-Female |
5.302400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.896400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.280810E-01 |
| Normal-vs-Age(61-80Yrs) |
5.559000E-03 |
| Normal-vs-Age(81-100Yrs) |
7.820000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.909200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.219700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.073800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.923700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.134810E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.009700E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.343200E-01 |
| Classical-VS-Follicular |
7.23670012803268E-10 |
| Classical-VS-Other |
4.030000E-01 |
| Classical-VS-Normal |
7.299400E-01 |
| Tall-VS-Follicular |
5.60600000000244E-05 |
| Tall-VS-Other |
2.505800E-01 |
| Tall-VS-Normal |
6.052200E-01 |
| Follicular-VS-Other |
2.380200E-01 |
| Follicular-VS-Normal |
5.5814999999626E-07 |
| Other-VS-Normal |
2.523400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.280550E-03 |
| Normal-vs-N1 |
3.648600E-01 |
| N0-vs-N1 |
1.410000E-01 |
|
|
